173 related articles for article (PubMed ID: 23767999)
21. Expression and clinical significance of Wee1 in colorectal cancer.
Egeland EV; Flatmark K; Nesland JM; Flørenes VA; Mælandsmo GM; Boye K
Tumour Biol; 2016 Sep; 37(9):12133-12140. PubMed ID: 27220319
[TBL] [Abstract][Full Text] [Related]
22. p16INK4a expression in invasive vulvar squamous cell carcinoma.
Tringler B; Grimm C; Dudek G; Zeillinger R; Tempfer C; Speiser P; Joura E; Reinthaller A; Hefler LA
Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):279-83. PubMed ID: 17721272
[TBL] [Abstract][Full Text] [Related]
23. p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group.
Woelber L; Prieske K; Eulenburg C; Oliveira-Ferrer L; de Gregorio N; Klapdor R; Kalder M; Braicu I; Fuerst S; Klar M; Strauss HG; Beckmann M; Meier W; Ignatov A; Mustea A; Jueckstock J; Schmidt G; Bauerschlag D; Hellriegel M; Canzler U; Petry KU; Kommoss S; Hantschmann P; Heubner M; Mahner S; Burandt E
Am J Obstet Gynecol; 2021 Jun; 224(6):595.e1-595.e11. PubMed ID: 33453182
[TBL] [Abstract][Full Text] [Related]
24. MiR-503 enhances the radiosensitivity of laryngeal carcinoma cells via the inhibition of WEE1.
Ma H; Lian R; Wu Z; Li X; Yu W; Shang Y; Guo X
Tumour Biol; 2017 Oct; 39(10):1010428317706224. PubMed ID: 29019284
[TBL] [Abstract][Full Text] [Related]
25. Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family.
Pouliot LM; Chen YC; Bai J; Guha R; Martin SE; Gottesman MM; Hall MD
Cancer Res; 2012 Nov; 72(22):5945-55. PubMed ID: 22942255
[TBL] [Abstract][Full Text] [Related]
26. Association of CXC chemokine receptor type 4 expression and clinicopathologic features in human vulvar cancer.
Shiozaki T; Tabata T; Ma N; Yamawaki T; Motohashi T; Kondo E; Tanida K; Okugawa T; Ikeda T
Int J Gynecol Cancer; 2013 Jul; 23(6):1111-7. PubMed ID: 23765204
[TBL] [Abstract][Full Text] [Related]
27. Cytokinetic effects of Wee1 disruption in pancreatic cancer.
Chang Q; Chandrashekhar M; Ketela T; Fedyshyn Y; Moffat J; Hedley D
Cell Cycle; 2016; 15(4):593-604. PubMed ID: 26890070
[TBL] [Abstract][Full Text] [Related]
28. Cytokeratin subtypes and involucrin in squamous cell carcinoma of the vulva. An immunohistochemical study of 41 cases.
Ansink A; Mooi WJ; van Doornewaard G; van Tinteren H; Heintz AP; Ivanyi D
Cancer; 1995 Aug; 76(4):638-43. PubMed ID: 8625158
[TBL] [Abstract][Full Text] [Related]
29. Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases.
Al-Ghamdi A; Freedman D; Miller D; Poh C; Rosin M; Zhang L; Gilks CB
Gynecol Oncol; 2002 Jan; 84(1):94-101. PubMed ID: 11748983
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical expression of thrombospondin-1 in invasive vulvar squamous cell carcinoma.
Tringler B; Grimm C; Sliutz G; Leodolter S; Speiser P; Reinthaller A; Hefler LA
Gynecol Oncol; 2005 Oct; 99(1):80-3. PubMed ID: 16009408
[TBL] [Abstract][Full Text] [Related]
31. The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned.
van de Nieuwenhof HP; van Kempen LC; de Hullu JA; Bekkers RL; Bulten J; Melchers WJ; Massuger LF
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2061-7. PubMed ID: 19567503
[TBL] [Abstract][Full Text] [Related]
32. LDOC1 as Negative Prognostic Marker for Vulvar Cancer Patients.
Wanka G; Schmoeckel E; Mayr D; Fuerst S; Kuhn C; Mahner S; Knabl J; Karsten MM; Dannecker C; Heidegger HH; Vattai A; Jeschke U; Jueckstock J
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291445
[TBL] [Abstract][Full Text] [Related]
33. Association of human papilloma virus status and response to radiotherapy in vulvar squamous cell carcinoma.
Proctor L; Hoang L; Moore J; Thompson E; Leung S; Natesan D; Chino J; Gilks B; McAlpine JN
Int J Gynecol Cancer; 2020 Jan; 30(1):100-106. PubMed ID: 31771962
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus infection and p16(INK4a) protein expression in vulvar intraepithelial neoplasia and invasive squamous cell carcinoma.
Rufforny I; Wilkinson EJ; Liu C; Zhu H; Buteral M; Massoll NA
J Low Genit Tract Dis; 2005 Apr; 9(2):108-13. PubMed ID: 15870532
[TBL] [Abstract][Full Text] [Related]
35. Cytokine, cell adhesion receptor, and tumor suppressor gene expression in vulvar squamous carcinoma: correlation with prominent fibromyxoid stromal response.
Ambros RA; Kallakury BV; Malfetano JH; Mihm MC
Int J Gynecol Pathol; 1996 Oct; 15(4):320-5. PubMed ID: 8886879
[TBL] [Abstract][Full Text] [Related]
36. MALDI Mass Spectrometry Imaging Reveals Decreased CK5 Levels in Vulvar Squamous Cell Carcinomas Compared to the Precursor Lesion Differentiated Vulvar Intraepithelial Neoplasia.
Zhang C; Arentz G; Winderbaum L; Lokman NA; Klingler-Hoffmann M; Mittal P; Carter C; Oehler MK; Hoffmann P
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399691
[TBL] [Abstract][Full Text] [Related]
37. EGFR expression in vulvar cancer: clinical implications and tumor heterogeneity.
de Melo Maia B; Fontes AM; Lavorato-Rocha AM; Rodrigues IS; de Brot L; Baiocchi G; Stiepcich MM; Soares FA; Rocha RM
Hum Pathol; 2014 May; 45(5):917-25. PubMed ID: 24746196
[TBL] [Abstract][Full Text] [Related]
38. In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastases.
Emanuels AG; Koudstaal J; Burger MP; Hollema H
Br J Cancer; 1999 Apr; 80(1-2):38-43. PubMed ID: 10389975
[TBL] [Abstract][Full Text] [Related]
39. Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia.
Carlson JA; Ambros R; Malfetano J; Ross J; Grabowski R; Lamb P; Figge H; Mihm MC
Hum Pathol; 1998 Sep; 29(9):932-48. PubMed ID: 9744309
[TBL] [Abstract][Full Text] [Related]
40. EGFR expression is associated with groin node metastases in vulvar cancer, but does not improve their prediction.
Oonk MH; de Bock GH; van der Veen DJ; Ten Hoor KA; de Hullu JA; Hollema H; van der Zee AG
Gynecol Oncol; 2007 Jan; 104(1):109-13. PubMed ID: 16963112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]